United Bank Gsk PLC Transaction History

United Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 05, 2018	SELL	$39.75 - $42.69 $211,271 - $226,897	-5,315 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$39.61 - $42.76 $24,914 - $26,896	-629 Reduced 10.58%	5,315 $214,000
Q1 2018 May 07, 2018	SELL	$36.18 - $40.15 $50,109 - $55,607	-1,385 Reduced 18.9%	5,944 $232,000
Q4 2017 Feb 07, 2018	SELL	$35.34 - $41.9 $93,686 - $111,076	-2,651 Reduced 26.56%	7,329 $260,000
Q3 2017 Nov 08, 2017	BUY	$39.44 - $41.55 $393,611 - $414,669	9,980	9,980 $405,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $78.7B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of United Bank, based on Form 13F filings with the SEC.

Stay updated on United Bank with notifications on news.